1. Home
  2. PESI vs LCTX Comparison

PESI vs LCTX Comparison

Compare PESI & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perma-Fix Environmental Services Inc.

PESI

Perma-Fix Environmental Services Inc.

N/A

Current Price

$16.30

Market Cap

367.9M

Sector

Industrials

ML Signal

N/A

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

N/A

Current Price

$1.09

Market Cap

301.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PESI
LCTX
Founded
1990
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Environmental Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
367.9M
301.7M
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
PESI
LCTX
Price
$16.30
$1.09
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$6.25
AVG Volume (30 Days)
463.8K
906.7K
Earning Date
05-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
43.61
N/A
EPS
N/A
N/A
Revenue
$642,000.00
$14,556,000.00
Revenue This Year
$34.62
$109.40
Revenue Next Year
$77.02
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
53.24
52 Week Low
$8.14
$1.00
52 Week High
$21.32
$2.09

Technical Indicators

Market Signals
Indicator
PESI
LCTX
Relative Strength Index (RSI) 47.30 44.84
Support Level $14.18 $1.00
Resistance Level $18.40 $1.18
Average True Range (ATR) 1.25 0.05
MACD -0.30 0.00
Stochastic Oscillator 7.09 32.14

Price Performance

Historical Comparison
PESI
LCTX

About PESI Perma-Fix Environmental Services Inc.

Perma-Fix Environmental Services Inc is a nuclear services company and provider of nuclear and mixed waste management services. The company's nuclear waste services include treatment and management of radioactive and mixed waste (waste containing both hazardous and low-level radioactive waste). The company operates through two segments: i) The treatment segment: It offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and ii) the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: